Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer
H Curé, V Chevalier, A Adenis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
P Rougier, A Adenis, M Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer
C Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
D Fallik, M Ychou, J Jacob, et al.
Mycopathologia
|
February 11, 2020
Re-drawing the Maps for Endemic Mycoses
Nida Ashraf, Ryan C Kubat, Victoria Poplin, et al.
British Journal of Cancer
|
October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, P L Etienne, et al.
British Journal of Cancer
|
September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
P Michel, A Adenis, F Di Fiore, et al.
British Journal of Cancer
|
October 24, 2013
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
A Adenis, I Ray-Coquard, A Italiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
D Malka, V Boige, N Jacques, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer
H Curé, V Chevalier, A Adenis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
P Rougier, A Adenis, M Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer
C Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
D Fallik, M Ychou, J Jacob, et al.
Mycopathologia
|
February 11, 2020
Re-drawing the Maps for Endemic Mycoses
Nida Ashraf, Ryan C Kubat, Victoria Poplin, et al.
British Journal of Cancer
|
October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, P L Etienne, et al.
British Journal of Cancer
|
September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
P Michel, A Adenis, F Di Fiore, et al.
British Journal of Cancer
|
October 24, 2013
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
A Adenis, I Ray-Coquard, A Italiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
D Malka, V Boige, N Jacques, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Page
of 11